1. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J. D. (1994). Molecular Biology of the Cell. 3rd edition, Garland, New York and London.
2. Aigle, M., and Lacroute, F. (1975). Genetic aspects of [URE3], a non-Mendelian, cytoplasmically-inherited mutation in yeast. Mol Gen Genet. 136:327–335.
3. Arrasate, M., Mitra, S., Schweitzer, E. S., Segal, M. R., and Finkbeiner, S. (2004). Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 431:805–810.
4. Bates, G. (2003). Huntingtin aggregation and toxicity in Huntington’s disease. Lancet. 361:1642–1644.
5. Berke, S. J., Schmied, F. A., Brunt, E. R., Ellerby, L. M., and Paulson, H. L. (2004). Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J Neurochem. 89:908–918.